What does PHARMA-THUILLIES do?

PHARMA-THUILLIES is a pharmacy in Thuin. Private Limited, started on 29 September 2014, 1 establishment.

What is the address of PHARMA-THUILLIES?

The registered office of PHARMA-THUILLIES is located at Rue de la Garenne(THL) 7, 6536 Thuin.

Is PHARMA-THUILLIES still active?

Yes. According to the CBE (30 October 2026) PHARMA-THUILLIES is active, legal situation “Normale toestand”, started on 29 September 2014.

Is PHARMA-THUILLIES registered on Peppol?

Yes, PHARMA-THUILLIES is registered on the Peppol network with ID 0208:0563416085.

What is the enterprise number of PHARMA-THUILLIES?

The enterprise number of PHARMA-THUILLIES is BE0563416085.

When was PHARMA-THUILLIES founded?

PHARMA-THUILLIES was founded on 29 September 2014.

Is PHARMA-THUILLIES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 September 2014; 5 annual accounts filed, latest fiscal year 2025.

How much profit did PHARMA-THUILLIES make in 2025?

PHARMA-THUILLIES posted a profit after taxes of € 48,309 in financial year 2025.

What is the revenue of PHARMA-THUILLIES?

As a small company, PHARMA-THUILLIES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 73,035.

Does PHARMA-THUILLIES have a website?

Yes, PHARMA-THUILLIES has a website at pharma-thuillies.be.

PHARMA-THUILLIES (Private Limited) - Thuin - BE0563416085

Dossier PHARMA-THUILLIES, printed on 30 October 2026 from databakkes.be/en/0563416085/pharma-thuillies. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMA-THUILLIES from Thuin, company number BE0563416085, closed financial year 2025 with a result of € 48,309 after tax. For that financial year PHARMA-THUILLIES recorded a gross margin of € 73,035 and equity of € 301,010. Compared with financial year 2024, the result moved from € 23,990 to € 48,309. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.

What it is worth Growing

€ 301,010

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 48,309

▲ 101% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 75,344

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 286,510.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 11,000

€ 6,421 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 46,788

▲ € 35,181 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 41,775

▼ 17% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 48,697 Gross margin 2022: € 48,697 First fiscal year in the series	€ 97,510 Gross margin 2023: € 97,510 ▲ 100% vs 2022 (€ 48,697) Favourable step	€ 59,649 Gross margin 2024: € 59,649 ▼ 39% vs 2023 (€ 97,510) Unfavourable step	€ 73,035 Gross margin 2025: € 73,035 ▲ 22% vs 2024 (€ 59,649) Favourable step	▲ 22%
Profit after taxes	€ 20,396 Profit after taxes 2022: € 20,396 First fiscal year in the series	€ 55,074 Profit after taxes 2023: € 55,074 ▲ 170% vs 2022 (€ 20,396) Favourable step	€ 23,990 Profit after taxes 2024: € 23,990 ▼ 56% vs 2023 (€ 55,074) Unfavourable step	€ 48,309 Profit after taxes 2025: € 48,309 ▲ 101% vs 2024 (€ 23,990) Favourable step	▲ 101%
Equity	€ 198,637 Equity 2022: € 198,637 First fiscal year in the series	€ 253,711 Equity 2023: € 253,711 ▲ 28% vs 2022 (€ 198,637) Favourable step	€ 252,701 Equity 2024: € 252,701 Unchanged (€ 253,711) Unfavourable step	€ 301,010 Equity 2025: € 301,010 ▲ 19% vs 2024 (€ 252,701) Favourable step	▲ 19%
Total debts	€ 86,051 Total debts 2022: € 86,051 First fiscal year in the series	€ 57,410 Total debts 2023: € 57,410 ▼ 33% vs 2022 (€ 86,051) Favourable step	€ 79,259 Total debts 2024: € 79,259 ▲ 38% vs 2023 (€ 57,410) Unfavourable step	€ 99,563 Total debts 2025: € 99,563 ▲ 26% vs 2024 (€ 79,259) Unfavourable step	▲ 26%
Cash	€ 41,371 Cash 2022: € 41,371 First fiscal year in the series	€ 37,008 Cash 2023: € 37,008 ▼ 11% vs 2022 (€ 41,371) Unfavourable step	€ 55,968 Cash 2024: € 55,968 ▲ 51% vs 2023 (€ 37,008) Favourable step	€ 75,344 Cash 2025: € 75,344 ▲ 35% vs 2024 (€ 55,968) Favourable step	▲ 35%
Retained profit	€ 184,137 Retained profit 2022: € 184,137 First fiscal year in the series	€ 239,211 Retained profit 2023: € 239,211 ▲ 30% vs 2022 (€ 184,137) Favourable step	€ 238,201 Retained profit 2024: € 238,201 Unchanged (€ 239,211) Unfavourable step	€ 286,510 Retained profit 2025: € 286,510 ▲ 20% vs 2024 (€ 238,201) Favourable step	▲ 20%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 25,000 Dividend 2024: € 25,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 25,000) Unchanged	▼ 100%
Bank debt	€ 61,546 Bank debt 2022: € 61,546 First fiscal year in the series	€ 34,550 Bank debt 2023: € 34,550 ▼ 44% vs 2022 (€ 61,546) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 34,550) Favourable step	€ 11,000 Bank debt 2025: € 11,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 284,687 Balance sheet total 2022: € 284,687 First fiscal year in the series	€ 311,121 Balance sheet total 2023: € 311,121 ▲ 9% vs 2022 (€ 284,687) Unchanged	€ 331,960 Balance sheet total 2024: € 331,960 ▲ 7% vs 2023 (€ 311,121) Unchanged	€ 400,573 Balance sheet total 2025: € 400,573 ▲ 21% vs 2024 (€ 331,960) Unchanged	▲ 21%

Key figures of PHARMA-THUILLIES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA-THUILLIES?

What happened at PHARMA-THUILLIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 15, 2026 New annual accounts for financial year 2025: profit of € 48,309 (▲ 101% vs 2024). filed late Source: NBB ↗
Sep 29, 2014 New establishment in Thuin. KBO
Sep 29, 2014 Start of the company according to the CBE. KBO

In short

From € 20,396 profit in 2022 to € 48,309 profit in 2025.

Paid € 77,743 in corporate taxes since 2022.

Best year ever: 2023, with € 55,074 profit.

Paid out € 25,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Garenne(THL) 7

6536 Thuin

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharma-thuillies.be

Technologies

ApacheBootstrapFont AwesomeVarnishjQueryjQuery UI

Hosting & Email

Email provider

one.com Mail

Hosting

ONECOM, DK

Website info

HTTPS Ja

Indexable pages 5

Languages FR

Features

Webshop Blog Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0563.416.085
VAT number: BE 0563.416.085
Registered office: Rue de la Garenne(THL) 7, 6536 Thuin
Names & denominations: PHARMA-THUILLIES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 September 2014
Peppol: Active · Active since 20 Nov 2025
Contact: pharma-thuillies.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA-THUILLIES